scholarly journals Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital

2015 ◽  
Vol 34 ◽  
pp. 79-83 ◽  
Author(s):  
Michael Osthoff ◽  
Sarah L. McGuinness ◽  
Aaron Z. Wagen ◽  
Damon P. Eisen
Author(s):  
Ayodele Oluwaseun Ajayi ◽  
Samuel Ayodeji Osanyinlusi ◽  
Oluwabukola Atinuke Popoola ◽  
Bryan Ogeneh

Urinary tract infection (UTI) is a huge public health problem and the emergence of extended spectrum-beta-lactamase producing bacterial pathogens increases the burden of infectious diseases in Nigeria. This study determined the current prevalence of cephalosporin resistance among Gram-negative bacteria isolated from patients with urinary tract infections between February 2018 and June 2018. This study was aimed to determine cephalosporin resistance prevalence among Gram-negative bacteria isolated from patients with urinary tract infections between February 2018 and June 2018. A total number of forty representative Gram-negative bacterial isolates namely Escherichia coli (n=14), Klebsiella pneumonia (n=9), Proteus mirabilis (n=12), and Klebsiella oxytoca (n=5) were subjected to polymerase chain reaction (PCR) to detect extended spectrum beta-lactamase (ESBL) genes using primers specific for blaTEM, blaSHV and blaCTX-M. The molecular evaluation indicated the presence of blaCTX-M gene in 20.0% of the tested organisms, while other ESBL genes variants were not detected.  The organisms carrying the blaCTX-M gene included E. coli (n=3, 37.5%), K. pneumoniae (n=1, 12.5%), P. mirabilis (n=1, 12.5%),) and K. oxytoca (n=3, 37.5%). The presence of cephalosporin resistant Gram-negative bacteria among patients with UTI may constitute a serious threat to public health and efforts must be intensified to regulate the clinical use of the cephalosporins.


2018 ◽  
Vol 10 (4) ◽  
pp. 222 ◽  
Author(s):  
Sundaram Balasubramanian ◽  
Dhanalakshmi Kuppuswamy ◽  
Swathi Padmanabhan ◽  
Vaishnavi Chandramohan ◽  
Sumanth Amperayani

2019 ◽  
Vol 6 (2) ◽  
Author(s):  
Dheeraj Goyal ◽  
Nathan Dean ◽  
Sarah Neill ◽  
Peter Jones ◽  
Kristin Dascomb

Abstract Background Community-acquired extended-spectrum beta-lactamase–producing Enterobacteriaceae (ESBL) infections are an evolving public health problem. Identifying predictive risk factors may improve patient management. Methods We identified 251 adult inpatients admitted to a 22-hospital system with an ESBL urinary tract infection (UTI) between 2001 and 2016. Cases were matched 1:1 with controls who had a UTI at admission with non-ESBL Enterobacteriaceae. Cases with a history of ESBL infections or hospitalization within 3 months of index admission were excluded. Univariate and multiple logistic regression were used to identify risk factors associated with ESBL UTIs. Results In univariate analysis, history of repeated UTIs, neurogenic bladder, urinary catheter presence at admission, and exposure to outpatient third-generation cephalosporins or fluoroquinolones within 3 months were associated with higher risk of ESBL UTIs. When controlling for severity of illness and comorbid conditions, history of repeated UTIs (adjusted odds ratio [aOR], 6.40; 95% confidence interval [CI], 3.42–12.66; P < .001), presence of urinary catheter at admission (aOR, 2.36; 95% CI, 1.15–4.98; P < .05), and prior antibiotic exposure (aOR, 7.98; 95% CI, 2.92–28.19; P < .001) remained associated with risk of ESBL infection. Conclusions Patients in the community with indwelling urinary catheters, history of recurrent UTIs, or recent antimicrobial use are at higher risk for de novo ESBL Enterobacteriaceae UTIs.


2012 ◽  
Vol 66 (9) ◽  
pp. 891-896 ◽  
Author(s):  
L. S. Briongos-Figuero ◽  
T. Gómez-Traveso ◽  
P. Bachiller-Luque ◽  
M. Domínguez-Gil González ◽  
A. Gómez-Nieto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document